FDA Adverse Event Malfunction Summary report: N

1823260-2015-04462

MDR report key: 5210335 · Received November 9, 2015

Report

Report Number
1823260-2015-04462
Event Type
Malfunction
Date Received
November 9, 2015
Date of Event
October 20, 2015
Report Date
November 18, 2015
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NE, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. ADDITIONAL INFORMATION FOR FURTHER INVESTIGATION WAS REQUESTED BUT WAS NOT PROVIDED. FROM THE PROVIDED DATA, A GENERAL REAGENT OR INSTRUMENT ISSUE WAS NOT IDENTIFIED.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE INTACT HUMAN CHORIONIC GONADOTROPIN + THE B-SUBUNIT (HCG+B) RESULTS FOR ONE PATIENT SAMPLE. THE INITIAL RESULT WAS >10000 MIU/ML. THE SAMPLE WAS RETESTED WITH A 1:100 ANALYZER DILUTION AND RESULT WAS 22671 MIU/ML. THIS DID NOT MATCH THE PATIENT'S PREVIOUS RESULT OF 89000 MIU/ML FROM (B)(6) 2015. THE CUSTOMER FOLLOWED UP WITH THE PATIENT'S DOCTOR AND CONFIRMED THE PATIENT HAD NOT MISCARRIED. THE CUSTOMER REPEATED THE SAME SAMPLE WITH A 1:100 ANALYZER DILUTION AND THE RESULT WAS 50399 MIU/ML. THE CUSTOMER THEN PERFORMED A MANUAL 1:100 DILUTION AND THE RESULT WAS 122700 MIU/ML. THIS RESULT WAS BELIEVED TO BE MORE IN LINE WITH THE PATIENT'S CLINICAL PROFILE. NO ERRONEOUS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE PATIENT WAS NOT ADVERSELY AFFECTED. THE REAGENT LOT NUMBER WAS 18742803. THE EXPIRATION DATE WAS 11/30/2016. THE FIELD SERVICE REPRESENTATIVE WAS UNABLE TO DUPLICATE THE ISSUE. HE CHECKED THE ADJUSTMENT OF THE SAMPLE POSITION, MIXING, REAGENT PROBES AND SIPPERS. HE FOUND THE PINCH VALVE TUBINGS WERE OK. HE ADJUSTED THE PROBE VOLTAGE, PERFORMED PREVENTIVE MAINTENANCE AND INSPECTIONS, AND REPLACED THE SEALS AND PINCH VALVE TUBINGS. HE RAN PERFORMANCE TESTING AND THE CUSTOMER RAN CALIBRATIONS AND QC WHICH WERE WITHIN SPECIFICATION.

Patients

Seq Age Sex Outcome Treatment
1 035 YR